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Abstract
The aim of the present study was to identify the signaling mechanisms to ghrelin-stimulated activation of the serine/
threonine kinase Akt. In human embryonic kidney 293 (HEK293) cells transfected with GHS-R1a, ghrelin leads to the
activation of Akt through the interplay of distinct signaling mechanisms: an early Gi/o protein-dependent pathway and a late
pathway mediated by b-arrestins. The starting point is the Gi/o-protein dependent PI3K activation that leads to the
membrane recruitment of Akt, which is phosphorylated at Y by c-Src with the subsequent phosphorylation at A-loop (T308)
and HM (S473) by PDK1 and mTORC2, respectively. Once the receptor is activated, a second signaling pathway is mediated
by b-arrestins 1 and 2, involving the recruitment of at least b-arrestins, c-Src and Akt. This b-arrestin-scaffolded complex
leads to full activation of Akt through PDK1 and mTORC2, which are not associated to the complex. In agreement with these
results, assays performed in 3T3-L1 preadipocyte cells indicate that b-arrestins and c-Src are implicated in the activation of
Akt in response to ghrelin through the GHS-R1a. In summary this work reveals that c-Src is crucially involved in the ghrelin-
mediated Akt activation. Furthermore, the results support the view that b-arrestins act as both scaffolding proteins and
signal transducers on Akt activation.
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Introduction
The growth hormone secretagogue receptor type 1a (GHS-
R1a
1) transduces the main signals carried by ghrelin participating
in the regulation of growth hormone release, food intake and
energy homeostasis [1]. Ghrelin stimulation of GHS-R1a results in
activation of heterotrimeric G proteins followed by receptor
phosphorylation that leads to the b-arrestin recruitment, which
then sterically interdicts further coupling to G proteins and targets
the receptor for internalization [2,3]. The ghrelin/GHS-R1a
complex is internalized by a clathrin-mediated mechanism
through an endosomal trafficking pathway. Once the ligand-
receptor complex is internalized into vesicles, GHS-R1a is sorted
into endosomes to be slowly recycled back to the plasma
membrane [2]. This slow recycling might be determined by the
stability of the complex GHS-R1a/b-arrestin during clathrin-
mediated endocytosis since this complex appears to dictate the
profile of the receptor resensitization [4]. Indeed, ghrelin-
stimulated GHS-R1a shows significant endosomal b-arrestin
recruitment [3]. In addition to the role of b-arrestin in terminating
G protein signaling, recent studies have demonstrated that b-
arrestins also function as scaffold molecules for numerous signaling
networks such as protein kinases, including the mitogen activated
protein kinases, extracellular signal-regulated kinase (ERK), c-Jun
NH2-terminal Kinase (JNK), and p38 mitogen-activated protein
kinase (p38), as well as Akt, PI3K and RhoA [5].
The signaling mechanisms that underlie the activation of the
mitogenic ERK growth response by the GHS-R1a are complex and
resultfrombothclassicalGprotein-regulated effectorsandb-arrestin
dependent ERK recruitment [6]. One pathway is Gi/o-dependent
and it is mediated by phosphatidylinositol 3-kinase (PI3K), protein
kinase Ce (PKCe) and non-receptor tyrosine kinase c-Src (c-Src).
The second pathway is Gq/11-dependent and involves the activation
of protein kinase Ca/b (PKCa/b) and c-Src. A third pathway
involves the recruitment of GHS-R1a, c-Src, Raf-1 and ERK 1/2
into a b-arrestin-scaffolded complex. G protein and b-arrestin
mediated ERK pathways are both temporally different and act in a
sequential way. The b-arrestin-scaffolded signaling complex persists
for prolonged periods and it is probably determined by the stability
of the b-arrestin /ghrelin receptor complexes. It has become
increasingly recognized that these scaffolding complexes can
determine the subcellular location and specificity, promoting
PLoS ONE | www.plosone.org 1 March 2009 | Volume 4 | Issue 3 | e4686Figure 1. Role of Gi/o proteins, Gbc dimers and PI3K in Akt phosphorylation in response to ghrelin. A, Time-course of the effect of
ghrelin on Akt HM (S473) and A-loop (T308) phosphorylation. B, Ghrelin-induced Akt phosphorylation in the absence or presence of PTX (100 ng/mL,
12 h), PI3K inhibitor wortmannin (1 mM, 30 min) and bc sequester b-ARK-CT. In A and B, serum-starved HEK-GHSR1a cells were treated with ghrelin
(100 nM) at 37uC for the indicated times. Cells were lysed and analyzed by SDS-PAGE using specific antibodies. Akt phosphorylation was quantified
by densitometry and expressed as a percentage of the maximal phosphorylation obtained for each residue (mean6S.E. of three independent
experiments). Blots are representative of three independent experiments.
doi:10.1371/journal.pone.0004686.g001
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PLoS ONE | www.plosone.org 2 March 2009 | Volume 4 | Issue 3 | e4686Figure 2. c-Src is required for phosphorylation of Akt in response to ghrelin. A, Effect of siRNA depletion of c-Src on ghrelin-induced Akt
phosphorylation. HEK-GHSR1a cells transfected with c-Src siRNA were serum-starved for 12 h and then stimulated with ghrelin (100 nM) at 37uC.
After stimulation, equal amounts of protein in each sample were used to assess the expression of c-Src (left panel) and Akt phosphorylation (right
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different physiological consequences [5].
The GHS-R1a has been implicated in Akt signaling, a serine/
threonine kinase that exerts a central role in the regulation of
metabolism, apoptosis, transcription and cell-cycle [7]. Although
previous studies have shown the activation of Akt in endothelial
[8–11], skeletal muscle [12], thyroid [13], preadipocytes [14] and
pancreatic cells [15], the molecular events that follow GHS-R1a
ligand binding to trigger Akt activation remain unknown. To
better understand these molecular mechanisms, we used HEK 293
cells stably expressing the GHS-R1a (HEK-GHSR1a) and 3T3-L1
preadipocyte cells. The experiments were designed to assess the
roles, if any, played by G proteins and b-arrestins.
Methods
Materials
Human ghrelin was obtained from Global Peptide (CO, USA).
Pertussis toxin was from Sigma (St. Louis, Mo, USA). Wortmannin,
PP2 and PP3 were purchased from Calbiochem (San Diego, CA,
USA). Anti-p44/42 MAPK rabbit polyclonal, anti-pSrc (Y416)
rabbit polyclonal, anti-pAkt HM (S473), anti-pAkt A-loop (T308),
anti-Akt rabbit polyclonal, anti-Rictor rabbit polyclonal, anti-
mTOR rabbit polyclonal and anti-pPDK1 (S241) rabbit polyclonal
antibodies were from Cell Signaling Technology (Beverly, MA,
USA). Rictor siRNA and siRNA control were synthesized by Cell
Signaling Technology (Beverly, MA, USA). Anti-pY rabbit poly-
clonal antibody was from Upstate Technology (Lake Placed, NY,
USA). Anti-b-arrestin 1 goat polyclonal, anti-b-arrestin 2 mouse
monoclonal and anti-c-Src rabbit polyclonal antibodies were from
Santa Cruz Biotechnology (Santa Cruz, CA, USA). b-arrestin 1
siRNA, b-arrestin 2 siRNA, c-Src siRNA and siRNA control were
likewise from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Anti-rabbit horseradish peroxidase was from GE-Amersham,
(Buckinghamshire, UK), while anti-goat horseradish peroxidase
was from Santa Cruz (Santa Cruz, CA, USA). Rabbit anti-rat b-
arrestin 1C-terminal (A1CT) antiserum was provided by Prof. R.J.
Lefkowitz (Duke University Medical Center, Durham, NC, USA).
Cell culture
HEK 293 cells, which stably express the human ghrelin receptor
1a (HEK-GHSR1a), were cultured as previously described [2].
3T3-L1 preadipocyte cells were obtained from American Type
Culture Collection and maintained in DMEM containing 10%
calf serum, 100 U/ml penicillin, and 100 U/ml streptomycin.
Cells were grown under a humidified atmosphere of 95% air, and
5% CO2 at 37uC.
Cell transient transfection
The cDNA encoding Gbc sequester b-ARK-CT (gift of P.
Voigt, Institute of Pharmacology, Charite ´-Medical Universiy,
Campus Benjamin Franklin, Berlin, Germany) was transfected
into subconfluent HEK-GHSR1a cells using Lipofectamine 2000
(Invitrogen; Carlsbad, CA, USA) following the manufacture’s
protocol. The b-ARK-CT incorporation was confirmed by means
of intracellular calcium measurements in transfected cells before
and after treatment as previously described [16].
Immunoblotting analysis
Serum-starved cells were stimulated with ghrelin for the
indicated time period at 37uC. The media was then aspirated
and the cells were lysed in ice-cold RIPA buffer [Tris-HCl
(pH 7.2), 50 mM; NaCl, 150 mM; EDTA, 1 mM; NP-40, 1% (v/
v); Na-deoxycholate, 0.25% (w/v); protease inhibitor cocktail
(Sigma; St. Louis, Mo, USA); phosphatase inhibitor cocktail
(Sigma; St. Louis, Mo, USA)]. The solubilized lysates were
transferred into centrifuge tubes and left at 4uC for 15 min, then
pre-cleared by centrifuging at 13,0006g for 15 min. Protein
concentration was evaluated with the QuantiPro
TM BCA assay kit
(Sigma; St. Louis, Mo, USA). Subsamples (same amount of
protein) of each sample were separated on 10% SDS-polyacryl-
amide gels and transferred to nitrocellulose membranes. The blots
were incubated with 5% non-fat dry milk in TBST [Tris-HCl
(pH 8.0), 20 mM; NaCl, 150 mM; Tween-20, 0.1% (v/v); used for
all incubation and washing steps] for 1 h. Next, blots were
incubated for 1 h with the corresponding antibodies according to
the manufacturer’s instructions. The blots were subsequently
incubated with the corresponding peroxidase-conjugated IgG
antibody. After washing, signals were visualized using an enhanced
chemiluminescence detection system (GE-Amersham; Buckin-
ghamshire, UK).
Immunoprecipitation
Serum-starved cells were stimulated with ghrelin for the
indicated time period at 37uC and lysed in ice-cold non-
denaturing NP-40 solubilization buffer [immunoprecipitation lysis
buffer (ILB), Tris-HCl (pH 7.5), 20 mM; NaCl, 150 mM; EDTA,
1 mM; NP-40, 1% (v/v); protease inhibitor cocktail (Sigma, St.
Louis, Mo, USA); phosphatase inhibitor cocktail (Sigma; St. Louis,
Mo, USA)]. 500 mg of total protein was pre-washed with 20 mLo f
50% protein A/G-agarose (Santa Cruz; Santa Cruz, CA, USA) for
30 min at 4uC, and then incubated with 1 mg of the corresponding
antibody (overnight at 4uC) followed by addition of 40 mL of 50%
protein A/G (2 h at 4uC). After washing two times with ILB, the
pelleted beads were resuspended in Laemmli sample buffer.
Proteins were analyzed by 10% SDS-polyacrylamide gels, followed
by Western blotting.
Small Interfering RNA (siRNA) Silencing of Gene
Expression
Chemically synthesized double-stranded siRNA duplexes (with
39 dTdT overhangs) were purchased from Santa Cruz Biothecnol-
ogy for the following targets: b-arrestin 1 (59-AAAGCCUU-
CUGCGCGGAGAAU-39), b-arrestin 2 (59-AAGGACCGCAAA-
GUGUUUGUG-39,5 9-AAAGCCUUCUGCGCGGAGAAU-39,
panel) by western blotting. Expression of c-Src was quantified by densitometry and expressed as percentages of the level of c-Src in control siRNA-
transfected cells (mean6S.E.). Akt phosphorylation was quantified by densitometry and expressed as a percentage of the maximal phosphorylation at
HM (S473) and A-loop (T308) after ghrelin addition to control siRNA-transfected cells (mean6S.E.). B, Effect of ghrelin on Y phosphorylation of Akt
and interaction between Akt and c-Src. Cells were incubated with ghrelin (100 nM, 5 min) at 37uC, lysed and immunoprecipitated (IP) with antibodies
to Akt, and then analyzed by western blotting with pAkt HM(S473), pY, pSrc (Y416) antibodies. C, Effect of ghrelin on Y phosphorylation of Akt in the
presence of c-Src siRNA. HEK-GHSR1a cells transfected with c-Src siRNA were serum-starved for 12 h and then stimulated with ghrelin (100 nM,
5 min) at 37uC. Equal amounts of protein in each sample were used to assess the expression of c-Src [upper panel; values shown (mean6S.E.) are
percentages of the level of c-Src in control siRNA-transfected cells]. Cells were lysed and immunoprecipitated (IP) with antibodies to Akt, and then
analyzed by western blotting with with pAkt HM(S473), pY, pSrc (Y416) antibodies. Immunoblots are representative of three independent
experiments.
doi:10.1371/journal.pone.0004686.g002
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PLoS ONE | www.plosone.org 4 March 2009 | Volume 4 | Issue 3 | e4686Figure 3. PDK1 and mTORC2 regulate Akt phosphorylation activated by ghrelin. A, Time-course of the effect of ghrelin (100 nM) on
phosphorylation of PDK1. Cell extracts were analyzed by SDS-PAGE using specific antibody against pPDK1 (S241) and Akt. PDK1 phosphorylation was
quantified by densitometry and expressed as a percentage of the maximal phosphorylation (mean6S.E of three independent experiments). B, PDK1
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UCGAUUAGUCAGAAA-39,5 9-CGCUUACUUUGCCUAA-
CAA-39,5 9-CCAACUGAGUGCAAUAUGU-39), c-Src (59-
CUCGGCUCAUUGAAGACA-39,5 9-UGACUGAGCUCAC-
CACAAA-39,5 9-CCUCAUCAUAGCAAUAACA-39,5 9-GUA-
GAUUUCAGAUGACUAU-39). A non-silencing RNA duplex
was used as a control for all siRNA experiments. Cells were
transfected with Lipofectamine 2000 (Invitrogen; Carlsbad, CA,
USA), according to manufacturers’ instructions. Silencing was
quantified by immunoblotting. Only experiments with verified
silencing were used.
Data analysis
The results were expressed as the mean6S.E. Differences
between means were evaluated by one-way analysis of variance
(ANOVA). (*,#, P,0.05).
Results
Akt temporal pattern activation by ghrelin
Figure 1A shows that Akt phosphorylation in both the activation
loop within the kinase domain [A-loop (T308)] and the
hydrophobic motif in the C-terminal region [HM (S473)] reached
maximal levels within 20 min of ghrelin stimulation (100 nM),
keeping the maximum by 60 min. The role of Gi/o protein was
evaluated by means of pretreatment with pertussis toxin, which
uncouples Gi/o protein from receptors (PTX; 100 ng/mL, 12 h).
As shown in Figure 1B, PTX reduced the ghrelin-induced
phosphorylation of the Akt A-loop (T308). Surprisingly, PTX
pretreatment showed an increase of Akt HM (S473) phosphory-
lation after ghrelin stimulation. Transfection with Gbc sequesters,
b-ARK-CT, decreased the effect of ghrelin on Akt phosphoryla-
tion at both residues, indicating the involvement of the bc-subunit
of G proteins (Fig. 1B). Pretreatment with the PI3K inhibitor
wortmannin (1 mM, 30 min) decreased the ghrelin-induced Akt
phosphorylation at both residues (Fig. 1B).
c-Src tyrosine kinase regulates Akt activity
Akt phosphorylation was strongly inhibited at both residues by
the selective Src inhibitor PP2 (5 mM, 30 min) for all time tested.
This inhibition was specific, since pretreatment with PP3 (5 mM,
30 min), a negative control for PP2, had no effect on the ghrelin-
induced Akt phosphorylation (data not shown). As shown in
Figure 2A, siRNA experiments targeting c-Src reduced its
expression by 5762% (Fig. 2A). In the presence of a non-targeting
control siRNA, ghrelin-activated Akt phosphorylation was iden-
tical to that observed without any transfection. c-Src siRNA
decreased ghrelin-activated Akt phosphorylation with respect to
siRNA control for all time tested [5463% at HM(S473); and,
4566% at A-loop(T308)]. Immunoprecipitation assays of Akt
showed an increase of Y phosphorylation of this kinase in ghrelin-
treated cells (100 nM, 5 min) in comparison with untreated cells
(Fig. 2B). Furthermore, the activated form of c-Src, pSrc (Y416),
co-immunoprecipitated with Akt, which demonstrates a direct
interaction between both kinases. Immunoprecipitation assays of
Akt in the presence of c-Src siRNA (6662% reduction in c-Src
expression) clearly decreased Y phosphorylation of this kinase in
ghrelin-treated cells (100 nM, 5 min) in comparison with non-
targeting control siRNA cells (Fig. 2C). c-Src siRNA decreased
ghrelin-activated Akt phosphorylation and coimmunoprecipitation
of pSrc (Y416) with respect to siRNA control.
3-phosphoinositide-dependent protein kinase 1 (PDK1)
and mammalian rapamycin-insensitive complex 2
(mTORC2) mediate Akt phosphorylation activated by
ghrelin
Figure 3A shows that pPDK1 (S241) reached maximal levels
within 5–10 min of ghrelin stimulation (100 nM), decreasing to
,50% of the maximum by 60 min after stimulation. This increase
was parallel to the phosphorylation of Akt A-loop (T308).
Pretreatment of cells with PTX (100 ng/mL, 12 h) had a
significant inhibitory effect on ghrelin-induced pPDK1 (S241)
(100 nM, 5 min). Inhibition of PI3K by wortmannin pretreatment
(1 mM, 30 min) inhibited the ghrelin-induced pPDK1 (S241)
(Fig. 3B). On the other hand, working in the presence of Rictor
siRNA (5062% reduction in Rictor expression; Fig. 3C), Akt HM
(S473) phosphorylation was reduced by 5064%, whereas A-loop
(T308) phosphorylation was not affected (Fig. 3C).
Regulation of Akt phosphorylation by b-arrestins
siRNA experiments targeting b-arrestin 1 or b-arrestin 2
reduced their expression by 4562% and 5564%, respectively
(Fig. 4A). In the presence of a non-targeting control siRNA,
ghrelin-activated Akt phosphorylation was identical to that
observed without any transfection (data not shown). b-arrestin 1
and b-arrestin 2 siRNA led to rapid Akt phosphorylation, which
decreased after 10 min of ghrelin stimulation with respect to
siRNA control [4162% and 3963% at HM(S473) for b-arrestin 1
and b-arrestin 2 siRNA, respectively; and, 4765% and 4064% at
A-loop(T308), for b-arrestin 1 and b-arrestin 2 siRNA, respectively
(Fig. 4A)]. This inhibitory effect stayed on both residues for at least
60 min. Immunoprecipitation of ghrelin-treated cells (100 nM,
10 min) with antibodies for b-arrestin 1 or b-arrestin 2
coprecipitated pAkt (T308, S473), while failed to coprecipitate
pPDK1 (S241), Rictor and mTOR (Fig. 4B). The b-arrestin-
dependent Akt phosphorylation was dependent on Src as no
immunoprecipitation of pAkt was obtained with antibodies to b-
arrestin 1 or b-arrestin 2 in ghrelin stimulated cells (100 nM,
10 min) after pretreatment with PP2 (5 mM, 30 min). This
inhibition was specific, since pretreatment with PP3 (5 mM,
30 min) had no effect on the b-arrestin-dependent Akt phosphor-
ylation induced by the agonist (data not shown).
Regulation of Akt phosphorylation by Src and b-arrestins
in 3T3-L1 preadipocyte cells
As shown in Figure 5A, both Akt A-loop (T308) and HM (S473)
phosphorylation reached maximal levels within 20–60 min of
ghrelin addition (100 nM). The Akt phosphorylation was inhibited
at both residues by pretreatment with PP2 (5 mM, 30 min)
phosphorylation induced by ghrelin (100 nM, 5 min) in the absence or presence of PTX (100 ng/mL, 12 h) and the PI3K inhibitor wortmannin (1 mM,
30 min). PDK1 phosphorylation was quantified by densitometry and expressed as the percentage of the basal phosphorylation obtained in control
cells (means6S.E.). C, Effects of siRNA depletion of Rictor on ghrelin-induced Akt phosphorylation. HEK-GHSR1a cells transfected with Rictor siRNA
were stimulated with ghrelin (100 nM) at 37uC. After stimulation, cell extracts were prepared as described in Experimental Procedures. Equal amounts
of protein in each sample were used to assess the expression of Rictor and Akt phosphorylation by Western blotting. Expression of Rictor was
quantified by densitometry. Shown values are percentages of the level of Rictor in control siRNA-transfected cells. Akt phosphorylation was
quantified by densitometry and expressed as a percentage of the maximal phosphorylation of Akt HM (S473) and A-loop (T308) after ghrelin
stimulation to control siRNA-transfected cells (mean6S.E.). In A, B and C, blots are representative of three independent experiments.
doi:10.1371/journal.pone.0004686.g003
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PLoS ONE | www.plosone.org 7 March 2009 | Volume 4 | Issue 3 | e4686(Fig. 5A). Immunoprecipitation of ghrelin-treated cells (100 nM,
10 min) with antibodies for b -arrestin 1 or b-arrestin 2
coprecipitated full-activated Akt showing an increase on tyrosine
phosphorylation compared to untreated cells (Fig. 5B). Further-
more, the activated form of Src, pSrc (Y416), co-immunoprecip-
itated with b-arrestin 1 or b-arrestin 2 (Fig. 5B).
Discussion
The present study offers three major findings related to the
activation of Akt in response to ghrelin. First, Akt is phosphor-
ylated by the interplay of two Gi/o-protein-dependent signaling
pathways. One pathway is Gbc-dependent and involves the
activation of PI3K. The second pathway is mediated by the b-
arrestins 1 and 2, and requires the entry of the receptor into a
multiprotein complex. Second, PDK1 and mTORC2 are essential
for A-loop and HM phosphorylation of Akt, respectively. Third, c-
Src plays an essential role in the activation of Akt mediated by
ghrelin. Thus, ghrelin activates Akt pools that differ in their
temporal and spatial distributions, suggesting to have different
physiological targets.
The protein kinase Akt has emerged as a pivotal signaling node
that regulates the control of cell proliferation, nutrient uptake and
metabolism in a cell-type-specific manner through a variety of
down-stream targets [7]. From the results presented so far, ghrelin
activates Akt by two distinct phosphorylation events, both of which
depend on PI3K. GHS-R1a activates PI3K through Gi/o protein
to regulate several downstream signaling pathways through the
generation of the lipid second messenger phosphatidylinositol-
3,4,5-triphosphate [PtdIns(3,4,5)P3] [6]. Since expression of Gbc
sequestrant inhibited both Akt HM (S473) and A-loop (T308)
phosphorylation, we suggest that Gbc dimers from Gi/o are the
upstream signal for PI3K activation [17]. PtdIns(3,4,5)P3 allows
membrane translocation of proteins containing PH domain such
as PDK1 and Akt. Then, PDK1 is autophosphorylated at Ser241
leading to its own activation and consequently phosphorylates Akt
A-loop (T308) [18,19]. Finally, the full activation of Akt involves
the phosphorylation of HM (S473). Several kinases, designated as
PDK2 kinases, have been proposed to phosphorylate the Akt HM
(S473) kinase; from those at least 10 of them may function as
PDK2, including integrin-linked kinase (ILK), protein kinase Ca
(PKCa), double-stranded DNA-dependent protein kinase (DNA-
PK), ataxia telangengiectasia mutated (ATM) gene product, and
the mTORC2 [20]. From all the proposed candidates, evidence
supports mTORC2 as the most compelling. mTORC2 contains
Rictor, mLST8, mSin1 variants and the mTOR kinase [21]. Our
study shows that ablating mTORC2 function by siRNA targeting
Rictor impaired ghrelin-stimulated HM (S473) phosphorylation of
Akt, but not at the A-loop (T308). This result identifies the
hypothetical ghrelin-activated PDK2 as mTORC2. The fact that
the Akt A-loop (T308) phosphorylation is unaffected by loss of HM
(S473) phosphorylation in mTORC2-deficient cells, supports that
the phosphorylation of HM (S473) is not critical for that of A-loop
(T308). Thus, the PDK1-mediated Akt A-loop (T308) phosphor-
ylation is not dependent on prior HM (S473) phosphorylation by
mTORC2 [22–25]. Interestingly, PTX treatment selectively
enhanced earliest time points of Akt HM (S473) phosphorylation,
consistent with a regulatory role of Gai/o protein. This opens the
possibility that Gai/o regulates the activation of the recently
discovered PH domain leucine-rich repeat phosphatase (PHLPP1
and PHLPP2), phosphatases that selectively dephosphorylate the
HM of Akt, resulting in decreased kinase activity [26,27]. These
results support the model by which both Akt and PDK1 interact
by colocalization at the plasma membrane, which is further
phosphorylated by mTORC2 [21]. Despite being a key element in
the Akt activation, the way mTORC2 is activated remains
unknown. Based on the PH-like domain of mSIN1, mTORC2 and
Akt might interact as consequence of colocalization at plasma
membrane when PI3K is activated [28]. This does not exclude the
possibility that other upstream signals regulate phosphorylation/
activation of the mTORC2 in response to different growth factors.
Indeed mSIN1 contains a Ras-binding domain raising the
possibility that Ras regulates mTORC2 [28,29].
c-Src kinase is involved in the MAPK activation in response to
ghrelin. Ghrelin induces a first ‘‘wave’’ of c-Src activation via G
protein-dependent signaling that it is followed by a second wave of
c-Src activation via b-arrestins-mediated signaling [6]. In the
present work, c-Src acts upstream of Akt, as c-Src depletion using
siRNAs reduced the ghrelin-induced Akt phosphorylation at both
A-loop (T308) and HM (S473). It was reported that, in addition to
phosphorylation of A-loop (T308) and HM (S473), Y phosphor-
ylation is also essential for Akt activation [30,31]. Our data
indicate that ghrelin activates Y phosphorylation of Akt, although
the detailed mechanism of this regulation remains to be elucidated.
Additionally, coimmunoprecipitation assays showed that c-Src
interacts with Akt in response to ghrelin. Because c-Src contains an
SH3 domain, it was proposed that Src interacts with the PXXP
motif of Akt [32]. Our data are consistent with this previously
proposed model in which Akt translocates to the plasma
membrane through the binding of its PH domain to
PtdIns(3,4,5)P3 generated by PI3K. This allows the interaction
of membrane bound Src and Akt through its PXXP motif in the
C-terminal regulatory region and the SH3 domain of Src. Then
Src phosphorylates Akt at Y residue(s), which triggers Akt A-loop
(T308) and HM (S473) phosphorylation by PDK1 and mTORC2
[32]. These data support the idea that Src operates as a ‘‘switch’’
in concert with PI3K for activation of Akt in response to ghrelin.
The existence of a pathway involving receptor endocytosis is
supported by the fact that b-arrestin depletion using siRNAs
reduced the magnitude of Akt activation by ghrelin. Our
coimmunoprecipitation assays indicate that the b-arrestins func-
tion as adaptors recruiting Akt to the ghrelin-occupied receptor
through the formation of b-arrestin complexes. The mechanism of
activation of Akt-associated to b-arrestins is not completely
delineated. From the data presented so far, c-Src is essential for
Akt activation even when is associated to b-arrestins. Given that c-
Figure 4. b-arrestins are required for the modulation of Akt phosphorylation in response to ghrelin. A, Effect of siRNA depletion of b-
arrestin 1 or b-arrestin 2 on ghrelin-induced Akt phosphorylation. HEK-GHSR1a cells transfected with b-arrestin 1 or b-arrestin 2 siRNA were serum-
starved for 12 h and then stimulated with ghrelin (100 nM) at 37uC. After stimulation, equal amounts of protein in each sample were used to assess
the expression of b-arrestin 1 or b-arrestin 2 (upper panel) and Akt phosphorylation (lower panel) by Western blotting. Expression of b-arrestin 1 or b-
arrestin 2 was quantified by densitometry. Values shown are percentages of the level of b-arrestins in control siRNA-transfected cells. Akt
phosphorylation was quantified by densitometry and expressed as a percentage of the maximal phosphorylation at HM (S473) and A-loop (T308)
after ghrelin addition to control siRNA-transfected cells (mean6S.E.). B, Effect of ghrelin on the assembly of complexes containing b-arrestins 1 and 2
and pAkt. Cells were incubated with ghrelin (100 nM, 10 min) at 37uC, lysed and immunoprecipitated (IP) with antibodies to b-arrestin 1 (left panel) or
b-arrestin 2 (right panel), and then analyzed by western blotting with pAkt[HM(S473), A-loop(T308), pPDK1 (S241)], Rictor, mTOR, and b-arrestin
(A1CT) antibodies. In A and B, western blots are representative of three independent experiments.
doi:10.1371/journal.pone.0004686.g004
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PLoS ONE | www.plosone.org 8 March 2009 | Volume 4 | Issue 3 | e4686Figure 5. Src and b-arrestins regulate Akt phosphorylation in response to ghrelin in 3T3-L1 preadipocyte cells. A, Effects of the Src
inhibitor PP2 and its negative control, PP3, on the ghrelin-induced Akt activation in 3T3-L1 preadipocyte cells. Serum-starved cells were pretreated
with PP2 (5 mM, 30 min) or PP3 (5 mM, 30 min) before ghrelin stimulation (100 nM) for the indicated time periods. Akt phosphorylation was
quantified by densitometry and expressed as a percentage of the maximal phosphorylation at HM (S473) and A-loop (T308) (mean6S.E of three
independent experiments). B, Effect of ghrelin on the assembly of complexes containing b-arrestins 1 and 2 and pAkt. Preadipocyte 3T3-L1 cells were
incubated with ghrelin (100 nM, 10 min) at 37uC, lysed and immunoprecipitated (IP) with antibodies to b-arrestins 1 and 2, and then analyzed by
western blotting with pAkt HM (S473), pAkt A-loop (T308), pY, pSrc (Y416) antibodies. For A and B, western blots are representative of three
independent experiments.
doi:10.1371/journal.pone.0004686.g005
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PLoS ONE | www.plosone.org 9 March 2009 | Volume 4 | Issue 3 | e4686Src is recruited to GHS-R1a upon ghrelin stimulation [6], it would
be possible that Akt interacts with Src associated to GHSR1a-b-
arrestin complex as consequence of colocalization at plasma
membrane when PI3K is activated in response to ghrelin. This
Akt-c-Src association is presumed to initiate Akt phosphorylation
by allowing Y phosphorylation. Furthermore, b-arrestin-scaffolded
complex presumably places the different components of the Akt
cascade in close proximity to each other and thus ensuring
substrate specificity. This is supported by the fact that neither
PDK1 nor mTORC2 coimmunoprecipitated with b-arrestins.
Interestingly, both b-arrestin 1 and b-arrestin 2 are required to
promote the activation of Akt. The requirement of both proteins
might be indicative of a need to form heterodimers to activate the
b-arrestin-dependent signaling pathway as it was described for
MAPK activation [6]. However, this cannot be generalized, since
in other systems b-arrestins show opposite effects. For example, in
the case of the D2-class receptors, b-arrestin 2 facilitates the
dephosphorylation of Akt by phosphatase 2 (PP2A) in response to
dopamine [33,34]. In addition, prostaglandin E2 [35], IGF-1 [36],
a-thrombin [37] and b1-adrenergic receptors [38,39] activate Akt
pathway through b-arrestin 1 dependent mechanisms. It seems
that each receptor determine the b-arrestin-associated functions
on basis of the receptor-associated isoforms.
It has been shown that ghrelin regulates the Akt activity through
the GHS-R1a in a variety of cellular systems [8–15]. Particularly,
the mitogenic effect of ghrelin in 3T3-L1 preadipocytes is
Figure 6. Model of upstream activation of Akt by ghrelin. Binding of ghrelin to GHS-R1a activates the generation of the second messenger
PtdIns(3,4,5)P3 (PIP3) by PI3K activation through Gi/o-protein dependent signaling pathway. Akt translocates to the plasma membrane by binding to
PIP3 where it is phosphorylated at Y by the membrane bound c-Src. This phosphorylation (Y) is followed by phosphorylation of Akt A-loop (T308) and
HM (S473) by PDK1 and mTORC2 respectively. Once the receptor is activated, a second signaling pathway is mediated by b-arrestins 1 and 2,
involving the recruitment of GHS-R1a, c-Src and Akt into an b-arrestin-scaffolded complex.
doi:10.1371/journal.pone.0004686.g006
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PLoS ONE | www.plosone.org 10 March 2009 | Volume 4 | Issue 3 | e4686mediated by the PI3K/Akt and MAPK pathways, via a Gi-protein
[14]. Accordingly to our results in HEK-GHSR1a cells, co-
immunoprecipitation assays performed in 3T3-L1 cells indicate
that b-arrestins recruit Akt, leading to its activation. c-Src acts
upstream of Akt in these cells, as PP2 abolished the ghrelin-
induced Akt phosphorylation at both residues. Furthermore, co-
immunoprecipitation assays showed that c-Src interacts with Akt
in response to ghrelin allowing the phosphorylation of Akt at Y
residue(s). Therefore, our data are consistent with a model in
which Akt translocates to the plasma membrane through the
binding of its PH domain to the second messenger PtdIns(3,4,5)P3
generated by PI3K which is activated through Gi/o-protein
dependent signaling pathway. Akt is phosphorylated at Y by the
membrane bound Src via the interaction between its C-terminal
proline-rich motif and the SH3 domain of Src. This Y
phosphorylation is followed by phosphorylation of Akt A-loop
(T308) and HM (S473) by PDK1 and mTORC2 respectively.
Once the receptor is activated, a second signaling pathway is
mediated by b-arrestins 1 and 2 involving the recruitment of GHS-
R1a, c-Src and Akt into an b-arrestin-scaffolded complex (Fig. 6).
Thus c-Src functions as a switch that initiates the Akt pathway
associated to both the Gi/o-protein dependent pathway and b-
arrestin-scaffolded complex.
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